new_0222_0352|LYEL|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0352|LYEL|1|Lyell Immunopharma Inc Total Current Assets (Quarterly) (USD)|Lyell Immunopharma Inc Cash and Short Term Investments (Quarterly) (USD)|Lyell Immunopharma Inc Inventories (Quarterly) (USD)|Lyell Immunopharma Inc Net PP&E (Quarterly) (USD)|Lyell Immunopharma Inc Goodwill and Intangibles (Quarterly) (USD)|Lyell Immunopharma Inc Total Liabilities (Quarterly) (USD)|Lyell Immunopharma Inc Total Current Liabilities (Quarterly) (USD)|Lyell Immunopharma Inc Total Long Term Liabilities (Quarterly) (USD)|Lyell Immunopharma Inc Total Deposits (Quarterly) (USD)|Lyell Immunopharma Inc Book Value (Quarterly) (USD)|Lyell Immunopharma Inc Retained Earnings (Quarterly) (USD)|Lyell Immunopharma Inc Treasury Stock (Quarterly) (USD)|Lyell Immunopharma Inc EV to Revenues|Lyell Immunopharma Inc EV to Earnings|Lyell Immunopharma Inc EV to Free Cash Flow|Lyell Immunopharma Inc EV to Assets (Quarterly)|Lyell Immunopharma Inc PS Ratio|Lyell Immunopharma Inc PE Ratio|Lyell Immunopharma Inc Price to Book Value|Lyell Immunopharma Inc PEG Ratio|Lyell Immunopharma Inc Debt to Equity Ratio|Lyell Immunopharma Inc Dividend Yield|Lyell Immunopharma Inc Shareholder Yield (TTM)|Lyell Immunopharma Inc Percent of Shares Outstanding Short|Lyell Immunopharma Inc Total Receivables (Quarterly) (USD)|Lyell Immunopharma Inc Total Payables (Quarterly) (USD)|Lyell Immunopharma Inc Total Capital Stock (Quarterly) (USD)|Lyell Immunopharma Inc Return on Invested Capital|Lyell Immunopharma Inc Quality Ratio Score|Lyell Immunopharma Inc Momentum Score|Lyell Immunopharma Inc Beta (1Y)|Lyell Immunopharma Inc Sustainable Growth Rate (TTM)|Lyell Immunopharma Inc Institutional Investor Ownership Percentage|Lyell Immunopharma Inc Average Diluted Shares Outstanding (Quarterly)|Lyell Immunopharma Inc Total Employees (Annual)|Lyell Immunopharma Inc EPS Diluted (Quarterly) (USD)|Lyell Immunopharma Inc Shares Outstanding|Lyell Immunopharma Inc Repurchase of Capital Stock (Quarterly) (USD)|Lyell Immunopharma Inc Ordinary Shares Number (Quarterly)|Lyell Immunopharma Inc Payout Ratio|Lyell Immunopharma Inc Quick Ratio (Quarterly)|Lyell Immunopharma Inc Normalized Diluted EPS (Quarterly) (USD)|Lyell Immunopharma Inc Stock Buybacks (Quarterly) (USD)|Lyell Immunopharma Inc Effective Tax Rate (TTM)|Lyell Immunopharma Inc Return on Equity|Lyell Immunopharma Inc Net Income (TTM) (USD)|Lyell Immunopharma Inc Revenue (TTM) (USD)|Lyell Immunopharma Inc Dividend Per Share (Quarterly) (USD)|Lyell Immunopharma Inc Revenue (Quarterly) (USD)|Lyell Immunopharma Inc Gross Profit (Quarterly) (USD)|Lyell Immunopharma Inc SG&A Expense (Quarterly) (USD)|Lyell Immunopharma Inc Pre-Tax Income (Quarterly) (USD)|Lyell Immunopharma Inc Net Income (Quarterly) (USD)|Lyell Immunopharma Inc Net Interest Income (Quarterly) (USD)|Lyell Immunopharma Inc Price (USD)|Lyell Immunopharma Inc Total Return Price (USD)|Lyell Immunopharma Inc Enterprise Value (USD)|Lyell Immunopharma Inc 30-Day Average Daily Volume|Lyell Immunopharma Inc 1 Year Price Returns (Daily)||
new_0222_0352|LYEL|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0352|LYEL|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly||
new_0222_0352|LYEL|5|91|91||91||91|91|91||91|91||1.44117647059|92|1.44117647059|92|1.43859649123||1.43827160494||91|1.44117647059|92|15.3571428571||91|91|92||||92|30.7142857143|91.3333333333||91.3333333333|29.8|91.3333333333|91|91|91|91.3333333333|91.3333333333||92|91|91||91.3333333333||91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.43859649123|1.43859649123|1.44117647059|1.43971631206|||
new_0222_0352|LYEL|6|3|3||3||3|3|3||3|3||170|1|170|1|171||162||3|170|1|14||3|3|1||||1|7|6||6|5|6|3|3|3|6|6||1|3|3||6||6|6|6|6|171|171|170|141|||
new_0222_0352|LYEL|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0352|LYEL|202003||||||||||||||||||||||||||||||||||211.746||-0.155||-16.05||||-0.155|11.806||||||1.256||8.88|-29.24|-29.24|2.341|||||||
new_0222_0352|LYEL|202006||||||||||||||||||||||||||||||||||211.746||-0.4754||||||-0.4754|||||||3.118||9.562|-100.656|-100.656|1.881|||||||
new_0222_0352|LYEL|202009||||||||||||||||||||||||||||||||||211.746||-0.1687||||||-0.1687|||||||1.07||13.57|-35.719|-35.719|1.096|||||||
new_0222_0352|LYEL|202012|617.547|612.619||124.055||189.84|49.285|140.555||-292.528|-334.143|||||||||||||||9.396|1010.97|||||||211.746||-0.1835|||242.83||12.4301|-0.1835||||-204.472|7.756||2.312||14.869|-38.857|-38.857|0.621|||||||
new_0222_0352|LYEL|202103|609.735|604.933||144.874||200.269|56.812|143.457||-334.048|-389.186|||||||||||||||7.121|1010.97|||||||211.746|190|-0.26|||242.83||10.648|-0.26||||-230.275|8.945||2.445||16.831|-55.043|-55.043|0.354|||||||
new_0222_0352|LYEL|202106|834.84|824.523||158.061||207.912|63.663|144.249||1021.955|-451.781||360.6757|-15.8652|-15.4748|2.4795|325.5448||3.7908||||-10.1409|0.5527||4.863|0.024|-23.8546||||-145.8454|33.5543|42.713||-1.47|238.549||238.549||12.9514|-1.47|-392.862||-145.8454|-192.214|8.455||2.628||19.112|-62.595|-62.595|0.218|16.24|16.24|3049.5128|475060.0333||14.5|15.79
new_0222_0352|LYEL|202109|631.147|618.921||163.093||211.86|59.281|152.579||986.474|-500.656||288.9503|-14.2667|-14.6553|2.445|257.4634||3.5975||||-11.0402|1.7817||3.526|0.024|-24.1343||||-59.4477|34.2608|239.384||-0.2|239.789||239.789||10.4405|-0.2|1.06||-59.4477|-205.37|10.14||2.755||21.241|-48.875|-48.875|0.27|14.8|14.8|2929.9562|677984.2333||13.94|9.55
new_0222_0352|LYEL|202112|||||||||||||122.5176||-6.214||134.6464||1.8868|||||3.1644|||||||||34.7164||||||||||||||||||||||7.74|7.74|1242.3284|765122.9333||5.68|5.97